(NASDAQ:MOTS) shares are moving up 24% in pre-market trading as shares are around .31 cents this morning. The company announced positive top line data.  More than 6,000 trades have gone off.

Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022

The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation

FORT LAUDERDALE, Fla., May 24, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today positive topline data from an investigator initiated EU study that show the Pure-Vu system provides adequate cleaning in patients with a history of poor bowel preparation. These data were presented in a poster during Digestive Disease Week 2022.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist